TRANSCRIPT

Q3 2023 — Earnings call remarks

Q3 2023PDF · 10 pages165 KB
1
Earnings Conference Call
Third Quarter 2023 Remarks
October 13, 2023
Moderator:
Good morning, and welcome to the UnitedHealth Group Third Quarter 2023 Earnings
Conference Call. A question and answer session will follow UnitedHealth Group’s prepared
remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains “forward-looking” statements
under U.S. federal securities laws. These statements are subject to risks and uncertainties that
could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with
the Securities and Exchange Commission, including the cautionary statements included in our
current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP
amounts is available on the “Financial & Earnings Reports” section of the company’s Investor
Relations page at www.unitedhealthgroup.com.
Information presented on this call is contained in the earnings release we issued this morning
and in our Form 8-K dated October 13, 2023, which may be accessed from the Investor
Relations page of the company’s website. I will now turn the conference over to the chief
executive officer of UnitedHealth Group, Andrew Witty.
Andrew Witty
Good morning and thank you for joining us. The third quarter results we reported today
reflect well-balanced and durable growth … supported by disciplined execution … and a
steadfast commitment to ensure high-quality, comprehensive care is well within reach
for every person we are privileged to serve.
Evolution in our marketplace, including regulatory changes, means agility and
adaptability must continue to be defining characteristics of our company. The people of

-- 1 of 10 --

2
Optum and UnitedHealthcare continuously strive to find new ways to innovate, serve
and grow.
As a direct result of their mission-driven focus, this year we’ll serve even more people,
more comprehensively than anticipated in the outlook we offered at the end of 2022. By
the close of this year, we will serve:
• Nearly 900,000 additional patients under value-based care arrangements at Optum
Health.
• Almost 1 million new consumers across UnitedHealthcare’s Medicare Advantage
offerings.
• And a total more than 1.5 billion scripts to the people who rely on Optum Rx.
Based on this performance, we are strengthening our 2023 adjusted earnings outlook to
a range of $24.85 to $25 dollars per share.
The confidence we have in our sustained long-term growth outlook is exemplified by the
14% third quarter revenue increase we reported this morning – more than $11 billion
above last year. The sources of this growth will drive many more years of strong
performance.
Value-based care is the centerpiece of our long-term strategy, precisely because it
delivers on the promise of high-quality clinical outcomes and experiences, at lower
costs than traditional models.
This year we expect Optum Health will serve more than 4 million people in fully
accountable relationships – almost twice as many people as we served just two years
ago. Many of these patients have serious health challenges … few economic
resources … and, until now, often had limited access to care … or the type of care they
truly need.

-- 2 of 10 --

3
Ramping up to engage these patients requires significant upfront investment and high-
touch reach. These early efforts ensure we can address patients’ unique needs and
design personalized care plans that drive better health outcomes, increase quality of life
and deliver cost savings throughout the health system. Making the investments to serve
people who have endured far too many barriers to care is an easy choice for us all.
In 2023, you have seen both our commitment and financial capacity to invest … to
further enable our ability to serve and to grow far into the future.
In recent years, we’ve invested significant resources in building our capabilities to care
for people most effectively for the life or health stage they find themselves in − whether
they need preventative or palliative care, or are best served in a clinic, at home or
virtually. In particular, we are advancing our ability to care for people in their homes and
integrating that physical care with our pharmacy and behavioral offerings. This work
means developing an even more versatile clinical workforce – to serve consumers in
more ways through clinic-based Optum care delivery capabilities … and extending our
reach to consumers who may not have ready access to physical clinics.
Medicare Advantage continues to be a powerful force in driving superior health
outcomes for consumers and in helping to lower costs at the system level. Today about
half of all seniors in the U.S. have chosen Medicare Advantage over traditional
Medicare … and that number will continue to expand … for very good reasons.
The results are well-documented – Medicare Advantage outperforms traditional fee-for-
service for seniors on many measures, including lower rates of hospitalization. And they
spend up to 45% less out of pocket compared to those in Medicare fee-for-service.
Importantly, this high value for consumers is delivered at a lower cost to the health
system.
UnitedHealthcare serves more people in high-quality, 4 Star and higher Medicare
Advantage plans than any other organization. Looking to the 2024 enrollment period,

-- 3 of 10 --

4
which begins Sunday, we are confident our offerings will again resonate with consumers
as they prioritize high-quality care and stable benefits.
In the reduced funding environment health plans face, I credit our teams for investing in
the areas consumers value most – including zero-dollar premium plans … no copays for
primary, virtual and preventative care … and no copays for hundreds of the most
commonly prescribed drugs.
I want to highlight one more aspect of our growth story – the consistently strong
performance of our pharmacy businesses.
Pharmacy, as you know, is the most common consumer touch point in health care.
What consumers and employers want more than anything is access to the most
effective treatments … in the moment they need them … for the lowest possible cost.
Optum Rx is delivering on those expectations. This most recent selling season is on
track to be among our strongest – reflecting a combination of new clients and retention
rates in the very high 90s. And as the coming season for 2025 develops, we’re
expecting another year of robust growth. Our clients tell us they value the
enhancements we are making to our pharmacy offerings – providing them transparency
and choice, while also integrating new tools and capabilities.
Notably, our pharmacy service offerings go far beyond the foundational benefit
management capabilities, and now account for about half of all Optum Rx revenues. We
continue to expand the reach of our community pharmacies, and our diverse specialty
and infusion offerings are growing double digits.
Driving this expanding market demand is the enormous pressure facing employers,
health plans, governments and others to manage and respond to manufacturer list
pricing. The services offered by Optum Rx and others are the only counterbalance to
drug company pricing. The foundational business objective for PBMs is to lower

-- 4 of 10 --

5
costs … and make medicines more affordable and accessible for individuals and
families. PBMs are the only entities in the drug supply chain with that exclusive focus
and incentive. And we’re honored to play this critical role.
These pillars of our growth – value-based care, pharmacy and our innovative benefits
businesses, alongside our health technology and financial service capabilities –
underpin our ability to develop ever stronger value propositions for the people who
receive and those who pay for care … and support our confidence in a future of growth.
And with that, I’ll pass it to Dirk McMahon, our president and COO.
Dirk McMahon
Thanks, Andrew.
I recently hosted UnitedHealthcare’s National Accounts forum, where we bring together
client leaders twice a year to share ideas and gather feedback. These are some of the
biggest and most sophisticated companies in America. They collectively employ and
sponsor coverage for millions of people.
And to no surprise, health care costs top their list of concerns, especially the rising cost
of drugs.
In addition, they want innovation – new tools to help their employees take full advantage
of their benefits, achieve better health outcomes and save money. And of course, it has
to be digital.
Let me offer a few examples of innovation that have fueled our growth outlook, starting
with our mobile platform, the primary access point for millions of UHC members. Each
year we add new capabilities to provide consumers with increased on-demand care
access, highly personalized information about their benefits, real-time support, cost
estimation tools, integrated pharmacy capabilities, and enhanced rewards.

-- 5 of 10 --

6
Another example: Our newest and fastest-growing commercial offerings, which feature
no annual deductibles and incentivize people to make good health care choices by
offering an unprecedented view into quality and cost. When seeking care options,
consumers see potential care providers’ latest reviews and quality designations, and
they see what they will actually pay for their care – which will help them make the most-
informed decisions.
UnitedHealthcare members in these offerings are receiving more preventative care
while paying about 50% less out of pocket compared to people enrolled in traditional
offerings … and their employers can reduce the total cost of care, with an average
savings of 11%. These results are why such new offerings are among our fastest
growing.
Beyond these consumer-facing innovations, we’re leveraging the latest technologies to
create greater operational capacity and productivity so we can better serve consumers
and focus on the highest-value work.
Our teams are significantly improving how quickly we respond to the millions of benefit
questions we receive each year.
We are using AI and natural language processing to expedite call documentation … to
rapidly generate accurate summaries of consumer interactions with our contact
centers – saving millions of dollars in administrative work and freeing up capacity for our
people to prioritize engagement.
We’re also utilizing these technologies to translate and interpret unstructured data such
as physician notes – which will help, for example, provide deeper insights for life
sciences customers so they can better assess the efficacy of their treatments.

-- 6 of 10 --

7
Of course, these are just a few of the hundreds of AI applications powered by Optum
Insight we are actively developing, testing and deploying today to further elevate the
consumer and care provider experience while driving increased quality and lower costs.
And with that, I’ll turn it over to our CFO, John Rex.
John Rex
Thank you, Dirk.
The growth we reported today is a direct result of investments made over many years to
develop and connect the diverse health capabilities needed to serve the people who
rely on us each day – while also creating the foundational capacity to serve millions
more in the years ahead. This capability development has long been in the making and
is still very much underway … as the opportunities to serve more people, more deeply,
continue to expand.
Before reviewing our business results, I’ll offer a few brief comments on care activity.
Care patterns remain consistent with the view we shared during the second quarter,
with activity levels still led by outpatient care for seniors – and still most notably in the
orthopedic and cardiac procedure categories. These trends remain stable at the levels
we previously described.
As we’ve noted, our outlook assumes these activity levels persist throughout next year.
We continuously monitor a broad spectrum of patient acuity levels and have yet to see
any other notable changes. For example, within oncology the average stage at which
we are first seeing cancer diagnoses remains consistent with historical patterns. As
always, we remain diligent in looking for changes to the underlying health of patients.
With that, let’s turn to our third quarter results.

-- 7 of 10 --

8
Revenues of $92.4 billion grew by 14% over the prior year, with double-digit growth
again at both Optum and UnitedHealthcare.
Optum Health revenues grew by 29% approaching $24 billion, driven by an increase in
the number of care services we offer and patients we serve, especially for those with
complex care needs. Operating margins continue to reflect the initial clinical
engagement activities that support the strong growth in patients we have realized this
year, as well as the higher care activity patterns we have discussed.
Optum Rx revenues grew by 14%, approaching $29 billion, driven by the strength in our
pharmacy care services offerings as well as new customer wins. Script growth of nearly
7% reflects customer response to our innovative solutions, which focus on choice and
lowest net cost.
Optum Insight revenues grew by 35% to $5 billion. Revenue backlog of over $31 billion
increased by more than $7 billion, in part due to the Change Healthcare combination. In
addition, we recently announced a partnership to provide revenue cycle, analytics and
information technology services to a health system serving more than 400,000 people in
the Midwest.
Turning to UnitedHealthcare:
Our commercial business added nearly 700,000 people through the third quarter.
Further, selling season indications are tracking favorably, particularly in national
accounts. So as ’24 begins, we expect to grow to serve an additional 1 million people
with commercial benefits.
Within our public sector programs, we expect growth of nearly 1 million Medicare
Advantage members this year. And looking to the year ahead, we’re encouraged by the
consumer value, stability and breadth of our offerings and, as always, we start with an
expectation that we will outpace overall market growth.

-- 8 of 10 --

9
Our Medicaid performance remains strong as we support people and families through
the redeterminations process. Our teams are really leaning in … speaking with
thousands of consumers each day. Through a comprehensive outreach program, we
are helping people navigate the process and connecting them with the resources they
need to retain or reinstate their health benefits or to help them find other affordable
coverages. A significant majority of the people we engage with are able to retain or
reinstate their coverage.
Our capital capacities remain strong. For the first nine months of the year, adjusted
cash flows from operations were at $22.4 billion or 1.3 times net income. And in that
same time frame, we returned over $11.5 billion to shareholders through dividends and
share repurchases.
As noted, given the strength of our business performance, this morning we have
updated our ’23 outlook for adjusted earnings to $24.85 to $25 dollars per share.
And as we finish strongly in ’23 and look forward to ’24, we’re intensely focused on
execution, while further expanding our capacities to serve more people, more deeply,
and building the foundations to support our growth objectives for years to come.
Now I’ll turn it back to Andrew.
Andrew Witty
Thanks, John.
Before opening up for questions, I’ll offer some preliminary observations about next
year, while reserving most of this conversation for our investor conference on
November 29th.
Our businesses continue to build momentum, while maintaining flexibility and
adaptability for an ever-changing landscape, even as we invest for the future. We’re

-- 9 of 10 --

10
focused on our strategic growth pillars and driving efficiencies throughout the enterprise
at an accelerated pace.
At this distance, analyst earnings estimates for 2024 reasonably reflect the performance
view we expect to offer in November, with consensus near the upper end of our likely
initial outlook range. Importantly, the growth we are realizing today, and our expanding
capacities serve to further reinforce the confidence we have in our long-term 13% to
16% growth objective.
###

-- 10 of 10 --